Amylyx Pharmaceuticals Inc (AMLX)’s Market Momentum: Closing Strong at 2.65, Up 1.15

Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As of close of business last night, Amylyx Pharmaceuticals Inc’s stock clocked out at $2.65, up 1.15% from its previous closing price of $2.62. In other words, the price has increased by $1.15 from its previous closing price. On the day, 0.71 million shares were traded. AMLX stock price reached its highest trading level at $2.68 during the session, while it also had its lowest trading level at $2.59.

Ratios:

To gain a deeper understanding of AMLX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.66 and its Current Ratio is at 4.66. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Mizuho on March 18, 2024, Downgraded its rating to Neutral and sets its target price to $4 from $32 previously.

On March 11, 2024, Robert W. Baird Downgraded its rating to Neutral which previously was Outperform and also lowered its target price recommendation from $37 to $4.

Leerink Partners Downgraded its Outperform to Market Perform on March 11, 2024, whereas the target price for the stock was revised from $27 to $4.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 12 ’24 when FRATES JAMES M bought 40,000 shares for $2.53 per share. The transaction valued at 101,368 led to the insider holds 233,464 shares of the business.

Firestone Karen bought 50,000 shares of AMLX for $106,590 on Sep 05 ’24. The Director now owns 55,000 shares after completing the transaction at $2.13 per share. On Sep 03 ’24, another insider, MILNE GEORGE M JR, who serves as the Director of the company, bought 100,000 shares for $2.20 each. As a result, the insider paid 219,800 and bolstered with 858,571 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AMLX now has a Market Capitalization of 180418624 and an Enterprise Value of -126252456. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.60 while its Price-to-Book (P/B) ratio in mrq is 0.69. Its current Enterprise Value per Revenue stands at -0.423 whereas that against EBITDA is 0.715.

Stock Price History:

Over the past 52 weeks, AMLX has reached a high of $20.44, while it has fallen to a 52-week low of $1.58. The 50-Day Moving Average of the stock is 25.62%, while the 200-Day Moving Average is calculated to be -61.02%.

Shares Statistics:

It appears that AMLX traded 1.62M shares on average per day over the past three months and 1023680 shares per day over the past ten days. A total of 67.71M shares are outstanding, with a floating share count of 41.20M. Insiders hold about 39.49% of the company’s shares, while institutions hold 61.49% stake in the company. Shares short for AMLX as of 1724976000 were 1487177 with a Short Ratio of 0.92, compared to 1722384000 on 1856225. Therefore, it implies a Short% of Shares Outstanding of 1487177 and a Short% of Float of 2.4.

Most Popular